Tag Archives: CLDT

Top 5 Stocks To Invest In 2021

Warren Buffett once said that when its comes to stocks, his “favorite holding period is forever.” Investors shouldn’t blindly apply that idea to all stocks, but holding the best stocks “forever” can mean the difference between a 10% gain and multi-bagger returns. Today, I’ll discuss three of my favorite long-term holdings, and why I don’t plan to sell them anytime soon.

Amazon

I bought Amazon (NASDAQ:AMZN) back in the low $600s, and it now trades at above $1,700. Yet I plan to keep holding the stock, because its growth story seems more compelling than ever.

Image source: Getty Images.

Amazon generates most of its revenue from its online marketplaces in over a dozen countries. Amazon locks in those customers with Prime, its premium plan, which offers discounts, free shipping, streaming media, and other perks.

Top 5 Stocks To Invest In 2021: Nuveen Core Equity Alpha Fund(JCE)

Nuveen Core Equity Alpha Fund (the Fund) is a diversified closed-end management investment company. The Fund’s investment objective is to provide total return. The Fund seeks to achieve its investment objective primarily through long-term capital appreciation, and secondarily through income and gains. The Fund will invest in a portfolio of common stocks selected by employing a mathematical process designed by its sub-advisor, Enhanced Investment Technologies, LLC (INTECH), which seeks to provide risk-adjusted excess returns (alpha) above the S&P 500 Index (the Index), with an equal or lesser amount of relative investment risk. The Fund will, to a limited extent, write (sell) call options primarily on custom baskets of securities that seek to track the return of the Index. Its investment advisor is Nuveen Asset Management (NAM), a wholly owned subsidiary of Nuveen Investments, Inc.

The Fund will invest its managed assets in a portfolio of common stocks from among the 500 stocks comprising the Index as selected by INTECH (the Equity Portfolio). INTECH will construct and manage the Equity Portfolio employing its mathematical process. Nuveen Core Equity Alpha Fund seeks to invest approximately 95% of its managed assets in the Equity Portfolio. The Fund will invest at least 80% of its managed assets in the Equity Portfolio. In constructing the Equity Portfolio, INTECH will employ its Large Cap Core strategy. The Large Cap Core strategy targets risk-adjusted excess returns for the Equity Portfolio (as distinguished from the Fund) over the Index of 3% to 4% annually. The Equity Portfolio will consist of a diversified portfolio of 250 to 450 common stocks included in the Index.

Nuveen Core Equity Alpha Fund may invest up to 10% of its managed assets in securities of other open or closed-end investment companies (including exchange-traded funds (ETFs)) that invest primarily in securities of the types, in which the Fund may invest directly and that have a similar investment objective! as that of the Fund. In addition, the Fund may invest a portion of its managed assets in pooled investment vehicles (other than investment companies) that invest primarily in securities of the types, in which the Fund may invest directly. The Fund may write call options on stock indexes or ETFs. It may invest in securities that, at the time of investment, are illiquid (securities that are not readily marketable). The Fund’s Equity Portfolio will be invested in liquid equity securities selected from the Index.

Advisors’ Opinion:

  • [By Max Byerly]

    Shaker Financial Services LLC lessened its holdings in shares of Nuveen Core Equity Alpha (NYSE:JCE) by 70.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 46,154 shares of the company’s stock after selling 112,257 shares during the period. Shaker Financial Services LLC’s holdings in Nuveen Core Equity Alpha were worth $674,000 at the end of the most recent reporting period.

Top 5 Stocks To Invest In 2021: Forest City Realty Trust, Inc.(FCE.A)

Forest City Realty Trust, Inc., incorporated on May 29, 2015, is engaged in the ownership, development, management and acquisition of commercial, and residential real estate and land throughout the United States. The Company’s segments include the Commercial Group, Residential Group, Land Development Group and Corporate Activities. The Company’s core markets include Boston, Chicago, Dallas, Denver, Los Angeles, Philadelphia, and the greater metropolitan areas of New York City, San Francisco and Washington D.C. The Company holds all of its assets, and conducts all of its business, through the Operating Partnership, Forest City Enterprises, L.P. The Company holds and operates certain of its assets through one or more taxable real estate investment trust (REIT) subsidiaries (TRSs).

Commercial Group

The Commercial Group segment owns, develops, acquires and operates regional malls, specialty/urban retail centers, office and life science buildings, and mixed-use projects. The Commercial Group segment’s portfolio is in both urban and suburban locations in approximately 10 states and the District of Columbia. The Commercial Group focuses on markets where it develops complex projects, employing public and/or private partnerships. In its office development activities, the Company is primarily a build-to-suit developer that works with tenants to meet their requirements. The Company’s office development focuses primarily on mixed-use projects in urban developments, often built in conjunction with hotels and/or retail centers or as part of an office or life science campus. Its regional malls are developed in collaboration with anchor stores that own their facilities as an integral part of the mall structure.

Residential Group

The Residential Group segment owns, develops, acquires, leases and manages residential rental properties in over 20 states and the District of Columbia. The Company is engaged in apartment community development. Its residential portfolio inc! ludes middle-market apartments, upscale urban properties, re-use developments, for-sale condominium projects and subsidized senior housing.

Land Development Group

The Land Development Group segment acquires and sells both land and developed lots to residential, commercial and industrial customers at its Stapleton project in Denver, Colorado. The Stapleton project is a urban redevelopment with future entitlements, including apartments, retail and office space, as well as single family neighborhoods, where the Company sells residential lots to homebuilders. The Company controls the development opportunity at Stapleton through an option agreement. The Company owns over 400 acres of undeveloped land (including approximately 160 saleable acres) and a purchase option for approximately 570 acres at Stapleton.

Advisors’ Opinion:

  • [By Max Byerly]

    Piedmont Office Realty Trust (NYSE: FCE.A) and Forest City Realty Trust (NYSE:FCE.A) are both mid-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Top 5 Stocks To Invest In 2021: Chatham Lodging Trust (REIT)(CLDT)

Chatham Lodging Trust, incorporated on October 26, 2009, is a real estate investment trust (REIT) organized to invest primarily in premium-branded upscale extended-stay and select-service hotels. All of the Company’s assets are held by, and all of its operations are conducted through, Chatham Lodging, L.P (Operating Partnership). The Operating Partnership and its subsidiaries lease the Company’s hotels. The Company owns approximately 40 hotels with over 5,680 (unaudited) rooms located in 15 states in the United States and the District of Columbia.

The Company’s hotels include upscale extended-stay hotels that operate under the Residence Inn by Marriott brand (over 10 hotels) and Homewood Suites by Hilton brand (approximately nine hotels), as well as premium-branded select-service hotels that operate under the Courtyard by Marriott brand (over four hotels), the Hampton Inn or Hampton Inn and Suites by Hilton brand (over three hotels), the SpringHill Suites by Marriott brand (approximately two hotels), the Hilton Garden Inn by Hilton brand (over two hotels) and the Hyatt Place brand (approximately two hotels). The service and amenity offerings of a few of these hotels include complimentary breakfast, Internet access, local calls, in-room movie channels, and daily linen and room cleaning service. Its hotels are located in Billerica, Massachusetts; Bloomington, Minnesota; Brentwood, Tennessee; Dallas, Texas; Farmington, Connecticut; Maitland, Florida; Houston, Texas; Altoona, Pennsylvania; Washington, Pennsylvania; Holtsville, New York; Garden Grove, California; Exeter, New Hampshire; Denver, Colorado; Savannah, Georgia, and Vienna, Virginia, among others.

Advisors’ Opinion:

  • [By Shane Hupp]

    TheStreet cut shares of Chatham Lodging Trust (NYSE:CLDT) from a b rating to a c+ rating in a research report report published on Thursday morning.

  • [By Motley Fool Transcribers]

    Chatham Lodging Trust  (NYSE:CLDT)Q4 2018 Earnings Conference CallFeb. 25, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Garrett Baldwin]

    There’s no guesswork involved, and the best part is – it’ll only take you 10 minutes per day! Click here now to start this once-in-a-lifetime journey…

    Stocks to Watch Today: KHC, HD, JWN, M, AAPL
    Kraft Heinz Co. (NYSE: KHC) is still licking its wounds after an abysmal earnings report on Thursday and a weak 2019 outlook. The consumer goods giant is looking to reshape its business as consumer tastes continue to evolve. According to reports, the firm – backed heavily by Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A) – is considering a deal to sell its Maxwell House brand. Warren Buffett is also affecting shares of Apple Inc. (NASDAQ: AAPL). Although AAPL stock added 0.4% in pre-market hours, Buffett said he would not purchase more shares of the company stock at these levels. However, should AAPL stock pull back in the near future, the “Oracle of Omaha” would consider purchasing more. Earnings season may be winding down, but concerns about the U.S. brick-and-mortar retail industry are always high. This week, Home Depot Inc. (NYSE: HD), Nordstrom Inc. (NYSE: JWN), and Macy’s Inc. (NYSE: M) will report earnings from the holiday quarter. Look for earnings reports from American States Water Co. (NYSE: AWR), Chatham Lodging Trust (NYSE: CLDT), EPR Properties (NYSE: EPR), Etsy Inc. (NASDAQ: ETSY), Life Storage Inc. (NYSE: LSI), Mosaic Co. (NYSE: MOS), Oneok Inc. (NYSE: OKE), Potbelly Corp. (NASDAQ: PBPB), Preferred Apartment Communities Inc. (NYSE: APTS), Rent-A-Center Inc. (NASDAQ: RCII), Shake Shack Inc. (NYSE: SHAK), and Tenet Healthcare Corp. (NYSE: THC).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top 5 Stocks To Invest In 2021: GlaxoSmithKline PLC(GSK)

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The company’s wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The company’s nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc has a collaboration agreements with Université de Sherbrooke and Pfizer Inc.; development agreement, and R and D collaboration with Propeller Health; and collaboration and license agreement with Idera pharmaceuticals, Inc. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.

Advisors’ Opinion:

  • [By ]

    GlaxoSmithKline (NYSE: GSK) has fought for its asthma drug Advair, including the patented inhaler, for a few years now. Now, however, it seems to be finally facing off against generic competition. Just a month ago, on February 8, GSK announced that it plans to make an “authorized generic” version of Advair available. This is likely in a response to the FDA approving the first generic version of Advair on January 30, and an attempt to save at least some of the $1.4 billion in annual sales.

  • [By Ethan Ryder]

    TRADEMARK VIOLATION NOTICE: “GlaxoSmithKline plc (GSK) Shares Bought by Usca Ria LLC” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4196137/glaxosmithkline-plc-gsk-shares-bought-by-usca-ria-llc.html.

Top 5 Stocks To Invest In 2021: BioPharmX Corporation(BPMX)

BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women’s health, dermatology, and otolaryngology markets. The company offers prescription, over-the-counter (OTC), and supplement products in oral, topical, inhalant, and/or injectable forms. It provides VI2OLET iodine, an OTC dietary supplement molecular iodine tablet that promotes overall breast health and for the alleviation of benign breast pain associated with fibrocystic breast condition. The company’s clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a non-lipophilic topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician’s practices, including OB-Gyn’s, dermatologists, and general practioners; and retail customers through retail sales channels and/or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Biopharmx Corp (NYSEAMERICAN:BPMX) were up 4.8% during mid-day trading on Tuesday . The stock traded as high as $0.22 and last traded at $0.20. Approximately 32,497 shares were traded during trading, a decline of 100% from the average daily volume of 8,266,355 shares. The stock had previously closed at $0.21.

Best Undervalued Stocks To Own For 2019

Related GWPH Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High GW Pharma Oncology Is Potential Underrated (Seeking Alpha)
Related ZYNE Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana Benzinga's Top Upgrades, Downgrades For February 24, 2017 Zynerba Pharmaceuticals Undervalued Compared To GW Pharmaceuticals (Seeking Alpha)

Top cannabis stocks took a hit Friday, after White House Press Secretary Sean Spicer suggested the federal government would enforce federal law in states where recreational weed has been legalized, even in spite of the Cole Memo.

Best Undervalued Stocks To Own For 2019: Chatham Lodging Trust (REIT)(CLDT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Teachers Insurance & Annuity Association of America raised its holdings in shares of Chatham Lodging (NYSE:CLDT) by 19.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 59,609 shares of the real estate investment trust’s stock after purchasing an additional 9,743 shares during the quarter. Teachers Insurance & Annuity Association of America owned 0.13% of Chatham Lodging worth $1,142,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Chatham Lodging Trust (NYSE:CLDT) from a sell rating to a hold rating in a research note released on Tuesday.

    Several other research firms have also recently weighed in on CLDT. Zacks Investment Research cut Chatham Lodging Trust from a hold rating to a sell rating in a research report on Friday, August 3rd. B. Riley increased their price objective on Chatham Lodging Trust from $20.00 to $21.00 and gave the stock a neutral rating in a research report on Thursday, August 2nd. TheStreet upgraded Chatham Lodging Trust from a c+ rating to a b- rating in a research report on Thursday, July 12th. Finally, Stifel Nicolaus reiterated a hold rating and set a $20.00 price objective on shares of Chatham Lodging Trust in a research report on Wednesday, August 1st. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. The stock has an average rating of Hold and an average price target of $21.20.

  • [By Shane Hupp]

    Chatham Lodging (NYSE:CLDT) announced a monthly dividend on Thursday, May 10th, Zacks reports. Shareholders of record on Thursday, May 31st will be paid a dividend of 0.11 per share by the real estate investment trust on Friday, June 29th. This represents a $1.32 annualized dividend and a yield of 6.38%. The ex-dividend date of this dividend is Wednesday, May 30th.

Best Undervalued Stocks To Own For 2019: TrovaGene, Inc.(TROV)

Advisors’ Opinion:

  • [By Paul Ausick]

    TrovaGene Inc. (NASDAQ: TROV) fell more than 55% Friday to post a new 52-week low of $0.79 after closing at $1.77 on Thursday. The 52-week high is $19.56. Volume of around 11 million was nearly five times the daily average of about 230,000. The company announced a public offering of $18 million in stock and warrants priced at $1.00 for the unit.

  • [By Stephan Byrd]

    TrovaGene Inc (NASDAQ:TROV) shares saw strong trading volume on Thursday . 1,477,200 shares were traded during trading, an increase of 185% from the previous session’s volume of 517,912 shares.The stock last traded at $0.83 and had previously closed at $0.81.

  • [By Logan Wallace]

    Media stories about TrovaGene (NASDAQ:TROV) have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. TrovaGene earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave news coverage about the medical research company an impact score of 45.974011377318 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    TrovaGene Inc (NASDAQ:TROV) has been assigned a consensus rating of “Hold” from the six research firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $7.00.

Best Undervalued Stocks To Own For 2019: Rocky Mountain Chocolate Factory Inc.(RMCF)

Advisors’ Opinion:

  • [By Max Byerly]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

  • [By Ethan Ryder]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

Best Undervalued Stocks To Own For 2019: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million

    Biotech

  • [By Sean Williams]

    This past week, the largest marijuana deal to date in the U.S. closed, with iAnthus Capital Holdings (NASDAQOTH:ITHUF) ponying up north of $600 million for MPX Bioceutical. Following closure of the deal, iAnthus now has 19 open locations spanning 11 states (it only had a presence in six states prior to the deal), but has retail licenses in place to open as many as 63 retail locations. What’s more, the combined company now has 210,000 square feet of aggregate grow space, but is targeting a near-tripling in this amount to 600,000 square feet, spread across the states it conducts business. 

  • [By Sean Williams]

    For instance, iAnthus Capital Holding (NASDAQOTH:ITHUF) recently completed the largest U.S. deal to date by purchasing MPX Bioceutical for around $600 million. (This deal will be eclipsed by MedMen’s purchase of PharmaCann, once that deal closes.) Though it’s unclear what sort of premium iAnthus paid for MPX Bioceutical as of yet, a quick glance at iAnthus Capital’s balance sheet shows that 55% of its total assets are currently tied up in goodwill. Since the dispensary space will presumably have plenty of competition, it’s unclear if iAnthus (or other acquisition-hungry dispensaries) will be able to recoup the premium it’s paid to buy other businesses. This leaves the door open for hefty future writedowns.

  • [By ]

    Much of the focus of cannabis investors has been centered on Canada and California. This makes sense given that they are the two largest recreational (or soon to be) cannabis markets in the world. However, one publicly traded company with US-centric cannabis operations has taken a different approach. iAnthus Capital is listed in Canada on the CSE (OTCQB:ITHUF), but is headquartered in New York and incorporated in Delaware. Unlike other Canadian-listed cannabis companies, most of which are aiming to get in on the highly competitive green-rush in California and Canada, iAnthus has set its sights on becoming the dominant player on the U.S. East Coast.

  • [By Sean Williams]

    It’s not even just a Canadian problem. iAnthus Capital Holdings (NASDAQOTH:ITHUF), a vertically integrated cannabis dispensary with a focus on the U.S. market, recently closed on its purchase of MPX Bioceutical. This roughly $600 million deal increases the number of states iAnthus has access to from six to 11, and lifts its retail license count to 63. But take a gander at its most recent quarterly filing and you’ll see that CA$7.2 million in goodwill has not so magically transformed into CA$75.9 million in goodwill over a nine-month period, through Sept. 30, 2018. This represents 55% of the company’s total assets.

  • [By Spencer Israel]

    The charts below are courtesy of VantagePoint, a platform that uses Artificial Intelligence and machine learning to forecast future price movements 1-3 days in advance with up to 86 percent accuracy. The blue line represents a predictive moving average that shows what’s going to happen three days in advance, and the black line is a simple 10-day moving average. A crossover of the blue line over the black line indicates a bullish signal from the software, and vice versa for a bearish signal.

    iAthus Capital Holdings, Inc. (OTC: ITHUF)

    Up 94 percent YTD

Best Undervalued Stocks To Own For 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Max Byerly]

    Antares Pharma (NASDAQ:ATRS) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Friday.

  • [By Ethan Ryder]

    Antares Pharma (NASDAQ:ATRS) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Friday.

  • [By Joseph Griffin]

    News articles about Antares Pharma (NASDAQ:ATRS) have trended somewhat positive on Sunday, according to Accern Sentiment. The research group scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Antares Pharma earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news coverage about the specialty pharmaceutical company an impact score of 45.2112654396991 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Motley Fool Transcribers]

    Antares Pharma Inc  (NASDAQ:ATRS)Q4 2018 Earnings Conference CallFeb. 28, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Stocks To Watch For 2019

Free Preview

For full access, Log in or Subscribe Now and get 4 weeks free!

Let’s face it, ladies, we are busy. Not regular busy, but super busy. All day, every day, and for years and years on end. You’ve heard that women are the ultimate multi-taskers or that popular piece of advice, “If you need something done, just give it to a busy woman.” Somehow, some way, women always get their multiple jobs done. Yet, it comes with a price.

Top 10 Stocks To Watch For 2019: TrovaGene, Inc.(TROV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media stories about TrovaGene (NASDAQ:TROV) have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. TrovaGene earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave news coverage about the medical research company an impact score of 45.974011377318 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Joseph Griffin]

    Here are some of the news stories that may have impacted Accern’s rankings:

    Get TrovaGene alerts:

    Average True Range under Consideration: TrovaGene, Inc. (NASDAQ:TROV), USD Partners LP (NYSE:USDP), Tiptree … (stocksnewspoint.com) Take These As A Wake-Up Call: TrovaGene, Inc. (NASDAQ:TROV), PPDAI Group Inc. (NYSE:PPDF), Inseego Corp … (journalfinance.net) Review of Financial analysis: TrovaGene, Inc., (NASDAQ: TROV), Redwood Trust, Inc., (NYSE: RWT) (globalexportlines.com) In which scenario TrovaGene, Inc. (TROV) and Urban Outfitters, Inc. (URBN) are Trading Now? (nmsunews.com) Analysts’ Views: Sumitomo Mitsui Financial Group Inc (SMFG) and Trovagene Inc (TROV) (postregistrar.com)

    TROV has been the topic of several recent research reports. Maxim Group reiterated a “hold” rating on shares of TrovaGene in a report on Monday, March 5th. HC Wainwright reiterated a “buy” rating and set a $12.00 target price on shares of TrovaGene in a report on Tuesday, March 6th. ValuEngine cut shares of TrovaGene from a “sell” rating to a “strong sell” rating in a report on Monday, April 2nd. Finally, Zacks Investment Research cut shares of TrovaGene from a “buy” rating to a “hold” rating in a report on Thursday, May 3rd. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. TrovaGene currently has an average rating of “Buy” and a consensus target price of $19.17.

  • [By Logan Wallace]

    TrovaGene Inc (NASDAQ:TROV) has been assigned a consensus rating of “Hold” from the six research firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $7.00.

  • [By Paul Ausick]

    TrovaGene Inc. (NASDAQ: TROV) fell more than 55% Friday to post a new 52-week low of $0.79 after closing at $1.77 on Thursday. The 52-week high is $19.56. Volume of around 11 million was nearly five times the daily average of about 230,000. The company announced a public offering of $18 million in stock and warrants priced at $1.00 for the unit.

  • [By Stephan Byrd]

    TrovaGene Inc (NASDAQ:TROV) shares saw strong trading volume on Thursday . 1,477,200 shares were traded during trading, an increase of 185% from the previous session’s volume of 517,912 shares.The stock last traded at $0.83 and had previously closed at $0.81.

Top 10 Stocks To Watch For 2019: Grupo Aeroportuario Del Pacifico, S.A. de C.V.(PAC)

Advisors’ Opinion:

  • [By Asit Sharma]

    Grupo Aeroportuario del Pacifico S.A.B. de C.V. (NYSE:PAC), Mexico’s largest private airport operator, completed the first half of 2018 with a modest surge in growth that allowed it to raise its full-year 2018 earnings outlook. The company, which refers to itself in shorthand as “GAP,” operates 12 Mexican airports, as well as Sangster International Airport in Montego Bay, Jamaica. The overarching numbers from GAP’s second-quarter 2018 report are as follows:

  • [By Motley Fool Staff]

    Right now, it’s time for that yearly review of the ones he picked to honor the month, and also the briefly famous pregnant giraffe: five companies, and the first letters of their tickers spelled out A-P-R-I-L. They were Axon Enterprise (NASDAQ:AAXN), Grupo Aeroportuario del Pacific (NYSE:PAC), ResMed (NYSE:RMD), Intuitive Surgical (NASDAQ:ISRG), and Live Nation (NYSE:LYV).

  • [By Logan Wallace]

    UBS Group upgraded shares of Grupo Aeroportr dl Pcfco SAB de CV (NYSE:PAC) from a market perform rating to an outperform rating in a research note released on Wednesday morning, thefly.com reports.

  • [By Asit Sharma]

    If you’re invested in Grupo Aeroportuario Del Pacifico (NYSE:PAC), you’ve probably gathered that it’s no cakewalk to obtain useful information on the Mexican airport operator. The company’s earnings filings contain some ingrained complexity due to reporting in the Mexican peso as a monetary unit. Further, adjustments under International Financial Reporting Standards have to be taken into account each quarter to understand operational performance. 

  • [By Asit Sharma]

    Mexican airport holding company Grupo Aeroportuario del Pacifico (NYSE:PAC) achieved a rare quarter in which its typical brisk top-line growth accelerated beyond the rate of service costs, leading to a double-digit rise in operating profit. After looking at the quarter’s numbers from 30,000 feet, we’ll reduce cruising altitude to examine salient details from the report that GAP (as the company refers to itself) issued on Thursday. Note that in the discussion that follows, all comparative numbers are presented against the prior-year quarter (the fourth quarter of 2017).

Top 10 Stocks To Watch For 2019: MB Financial Inc.(MBFI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Bank of New York Mellon Corp lowered its position in shares of MB Financial Inc (NASDAQ:MBFI) by 1.8% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,311,121 shares of the bank’s stock after selling 24,208 shares during the quarter. Bank of New York Mellon Corp owned about 1.56% of MB Financial worth $61,229,000 as of its most recent SEC filing.

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MB Financial (MBFI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares surged 296.07 percent to close at $1.25 on Monday after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares gained 19.59 percent to close at $2.93.
    TransGlobe Energy Corporation (NASDAQ: TGA) rose 18.39 percent to close at $2.64 on Monday.
    Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) shares gained 15.91 percent to close at $2.55.
    VAALCO Energy, Inc. (NYSE: EGY) shares jumped 14.9 percent to close at $2.39.
    Resonant Inc. (NASDAQ: RESN) climbed 13.96 percent to close at $4.49.
    Chesapeake Energy Corporation (NYSE: CHK) shares rose 13.55 percent to close at $4.61 on Monday.
    Lilis Energy, Inc. (NYSE: LLEX) surged 13.09 percent to close at $5.01.
    MB Financial, Inc. (NASDAQ: MBFI) gained 12.9 percent to close at $49.28. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 12.83 percent to close at $3.43.
    World Wrestling Entertainment, Inc. (NYSE: WWE) jumped 12.52 percent to close at $57.86 on Reports that it has reached a deal with Fox for Its 'Smackdown Live' program.
    Eastman Kodak Company (NASDAQ: KODK) rose 12.38 percent to close at $5.90.
    NuCana plc (NASDAQ: NCNA) climbed 11.94 percent to close at $26.44. NuCana appointed Dr. Cyrille Leperlier to its Board as an independent non-executive Director.
    Aqua Metals, Inc. (NASDAQ: AQMS) rose 11.83 percent to close at $3.97 on Monday.
    Huami Corporation (NYSE: HMI) shares jumped 11.27 percent to close at $10.17 following Q1 results.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 9.55 percent to close at $7.34.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.56 percent to close at $7.86 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the de
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on MB Financial (MBFI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Watch For 2019: Harsco Corporation(HSC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Harsco Co. (NYSE:HSC) has earned an average recommendation of “Buy” from the eight ratings firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $29.50.

  • [By Joseph Griffin]

    HashCoin (CURRENCY:HSC) traded up 2.5% against the dollar during the 1-day period ending at 17:00 PM ET on July 17th. One HashCoin token can now be purchased for about $0.0025 or 0.00000034 BTC on exchanges including Gate.io and BCEX. HashCoin has a market cap of $0.00 and $2.52 million worth of HashCoin was traded on exchanges in the last day. During the last week, HashCoin has traded 3.7% higher against the dollar.

  • [By Joseph Griffin]

    HashCoin (CURRENCY:HSC) traded 2.5% lower against the US dollar during the 1 day period ending at 20:00 PM ET on September 30th. HashCoin has a total market capitalization of $0.00 and $28,133.00 worth of HashCoin was traded on exchanges in the last day. One HashCoin token can currently be purchased for approximately $0.0004 or 0.00000005 BTC on exchanges including Gate.io and BCEX. Over the last week, HashCoin has traded down 5.5% against the US dollar.

  • [By Max Byerly]

    Principal Financial Group Inc. boosted its position in shares of Harsco Co. (NYSE:HSC) by 2.4% during the 1st quarter, HoldingsChannel reports. The fund owned 654,139 shares of the industrial products company’s stock after buying an additional 15,559 shares during the quarter. Principal Financial Group Inc.’s holdings in Harsco were worth $13,508,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Stocks To Watch For 2019: Voya Global Equity Dividend and Premium Opportunity Fund(IGD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Voya Global Equity Div & Prm Oppty Fund (NYSE:IGD) declared a monthly dividend on Tuesday, September 18th, Wall Street Journal reports. Shareholders of record on Tuesday, October 2nd will be given a dividend of 0.061 per share by the investment management company on Monday, October 15th. This represents a $0.73 dividend on an annualized basis and a yield of 9.89%. The ex-dividend date of this dividend is Monday, October 1st.

Top 10 Stocks To Watch For 2019: Brooks Automation Inc.(BRKS)

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    Brooks Automation (NASDAQ:BRKS) Q1 2019 Earnings Conference CallFeb. 5, 2019 5:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Brooks Automation (NASDAQ: BRKS) and Amtech Systems (NASDAQ:ASYS) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

  • [By Stephan Byrd]

    Shares of Brooks Automation, Inc (NASDAQ:BRKS) have earned an average recommendation of “Buy” from the ten research firms that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $40.67.

Top 10 Stocks To Watch For 2019: Axcelis Technologies Inc.(ACLS)

Advisors’ Opinion:

  • [By ]

    3. Axcelis Technologies (Nasdaq: ACLS)
    It is the technical price pattern that first caught my eye with this $800 million market cap small cap.  Shares dropped to a $22.00 low in mid-February but have since been slowly and steadily moving higher toward resistance at both the 50- and 200-day SMAs. In and of itself, this is not enough impetus to get long. However, when combined with the fundamental picture, a compelling long thesis emerges.

  • [By Shane Hupp]

    Shares of Axcelis Technologies (NASDAQ:ACLS) have been assigned an average recommendation of “Buy” from the nine analysts that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $30.50.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribing]

    Axcelis Technologies (NASDAQ:ACLS) Q4 2018 Earnings Conference CallFeb. 7, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Stocks To Watch For 2019: iKang Healthcare Group, Inc.(KANG)

Advisors’ Opinion:

  • [By Shane Hupp]

    TheStreet cut shares of iKang Healthcare Group (NASDAQ:KANG) from a c rating to a d+ rating in a research note released on Wednesday morning.

    Other equities research analysts have also recently issued reports about the stock. BidaskClub cut shares of iKang Healthcare Group from a strong-buy rating to a buy rating in a report on Tuesday, May 8th. ValuEngine upgraded shares of iKang Healthcare Group from a hold rating to a buy rating in a report on Saturday, June 2nd.

  • [By Motley Fool Staff]

    iKang Healthcare Group (NASDAQ:KANG) Q4 2017 Earnings Conference CallJun. 22, 2018 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    BidaskClub upgraded shares of iKang Healthcare Group (NASDAQ:KANG) from a strong sell rating to a sell rating in a research note released on Tuesday.

Top 10 Stocks To Watch For 2019: Chatham Lodging Trust (REIT)(CLDT)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    There’s no guesswork involved, and the best part is – it’ll only take you 10 minutes per day! Click here now to start this once-in-a-lifetime journey…

    Stocks to Watch Today: KHC, HD, JWN, M, AAPL
    Kraft Heinz Co. (NYSE: KHC) is still licking its wounds after an abysmal earnings report on Thursday and a weak 2019 outlook. The consumer goods giant is looking to reshape its business as consumer tastes continue to evolve. According to reports, the firm – backed heavily by Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK.A) – is considering a deal to sell its Maxwell House brand. Warren Buffett is also affecting shares of Apple Inc. (NASDAQ: AAPL). Although AAPL stock added 0.4% in pre-market hours, Buffett said he would not purchase more shares of the company stock at these levels. However, should AAPL stock pull back in the near future, the “Oracle of Omaha” would consider purchasing more. Earnings season may be winding down, but concerns about the U.S. brick-and-mortar retail industry are always high. This week, Home Depot Inc. (NYSE: HD), Nordstrom Inc. (NYSE: JWN), and Macy’s Inc. (NYSE: M) will report earnings from the holiday quarter. Look for earnings reports from American States Water Co. (NYSE: AWR), Chatham Lodging Trust (NYSE: CLDT), EPR Properties (NYSE: EPR), Etsy Inc. (NASDAQ: ETSY), Life Storage Inc. (NYSE: LSI), Mosaic Co. (NYSE: MOS), Oneok Inc. (NYSE: OKE), Potbelly Corp. (NASDAQ: PBPB), Preferred Apartment Communities Inc. (NYSE: APTS), Rent-A-Center Inc. (NASDAQ: RCII), Shake Shack Inc. (NYSE: SHAK), and Tenet Healthcare Corp. (NYSE: THC).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Chatham Lodging Trust (NYSE:CLDT) from a sell rating to a hold rating in a research note released on Tuesday.

    Several other research firms have also recently weighed in on CLDT. Zacks Investment Research cut Chatham Lodging Trust from a hold rating to a sell rating in a research report on Friday, August 3rd. B. Riley increased their price objective on Chatham Lodging Trust from $20.00 to $21.00 and gave the stock a neutral rating in a research report on Thursday, August 2nd. TheStreet upgraded Chatham Lodging Trust from a c+ rating to a b- rating in a research report on Thursday, July 12th. Finally, Stifel Nicolaus reiterated a hold rating and set a $20.00 price objective on shares of Chatham Lodging Trust in a research report on Wednesday, August 1st. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. The stock has an average rating of Hold and an average price target of $21.20.

  • [By Motley Fool Transcribers]

    Chatham Lodging Trust  (NYSE:CLDT)Q4 2018 Earnings Conference CallFeb. 25, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Stocks To Watch For 2019: Duluth Holdings Inc.(DLTH)

Advisors’ Opinion:

  • [By Brian Feroldi]

    Duluth Holdings (NASDAQ:DLTH) reported its fiscal first-quarter results on Tuesday, June 5. The maker of premium rough-and-tumble clothing and gear reported strong top-line growth of nearly 20% thanks to 13 new store openings over the last year. However, the company struggled to translate it into gains on the bottom line. 

  • [By Shane Hupp]

    Shares of Duluth Holdings Inc (NASDAQ:DLTH) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $23.60 and last traded at $23.54, with a volume of 43126 shares. The stock had previously closed at $22.52.

  • [By Stephan Byrd]

    Express (NYSE: EXPR) and Duluth (NASDAQ:DLTH) are both small-cap retail/wholesale companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Best Value Stocks For 2019

Pacific Heights Asset Management LLC trimmed its holdings in shares of Morgan Stanley (NYSE:MS) by 18.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 215,000 shares of the financial services provider’s stock after selling 50,000 shares during the quarter. Pacific Heights Asset Management LLC’s holdings in Morgan Stanley were worth $11,601,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Whittier Trust Co. of Nevada Inc. lifted its position in shares of Morgan Stanley by 406.5% during the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 1,869 shares of the financial services provider’s stock valued at $101,000 after acquiring an additional 1,500 shares during the period. Exane Derivatives lifted its position in shares of Morgan Stanley by 303.9% during the 4th quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock valued at $104,000 after acquiring an additional 1,489 shares during the period. First Dallas Securities Inc. acquired a new position in shares of Morgan Stanley during the 4th quarter valued at $121,000. Guidant Wealth Advisors acquired a new position in shares of Morgan Stanley during the 4th quarter valued at $132,000. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its position in shares of Morgan Stanley by 119.4% during the 4th quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,800 shares of the financial services provider’s stock valued at $147,000 after acquiring an additional 1,524 shares during the period. 86.98% of the stock is currently owned by hedge funds and other institutional investors.

Best Value Stocks For 2019: Kura Oncology, Inc.(KURA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Kura Oncology (NASDAQ:KURA) was the target of unusually large options trading on Thursday. Stock investors bought 699 put options on the company. This represents an increase of 694% compared to the typical daily volume of 88 put options.

Best Value Stocks For 2019: Avago Technologies Limited(AVGO)

Advisors’ Opinion:

  • [By ]

    The path has been beset with challenges, from a hostile takeover attempt by Hock Tan’s Broadcom Corp. (AVGO) to an epic IP battle with Apple Inc. (AAPL) and a landmark acquisition of NXP Semiconductors NV (NXPI) that faced an activist campaign by Elliott Management Corp. and a protracted review by regulators in China.

  • [By Garrett Baldwin]

    Shares of General Electric Co. (NYSE: GE) are in focus after the company reported earnings before the bell. GE stock popped 5.6% after the firm topped earnings per share (EPS) estimates by $0.05 and backed its 2018 outlook. The firm reported EPS of $0.16 on top of $28.66 billion in revenue. GE stock had been off nearly 18% from its last earnings report on January 24 due to ongoing financial and legal problems.
    Crude oil prices dipped Friday after U.S. President Donald Trump took aim at OPEC. Trump accused the cartel of keeping oil prices “artificially high” despite “record amounts of oil all over the place.” Brent crude and WTI crude oil both hit three-year highs this week after Saudi Arabia suggested that it was working to press oil prices back above $100 per barrel.
    Three Stocks to Watch Today: PM, MO, WFC
    Shares of Philip Morris International Inc.(NYSE: PM) fell this morning after the firm experienced its worst trading day since its spin-off from Altria Group Inc. (NYSE: MO). Shares of PM fell as much as 16% after the firm fell short of revenue expectations after the bell. MO stock fell roughly 6% on the day.
    Shares of Wells Fargo & Co. (NYSE: WFC) are under pressure after The New York Times reported that the firm may be facing a $1 billion fine. The fines would cover a variety of “alleged” misdeeds that include the firm’s push on customers to purchase auto insurance they didn’t need and charging mortgage customers fees for services that they were not using. The Consumer Financial Protection Bureau and the Office of the Comptroller of the Currency will most likely announce the fine today. Money MorningCapital Wave StrategistShah Gilani weighed in on the topic this week, and he offers a scorching indictment.
    Qualcomm Inc. (Nasdaq: QCOM) is on the move today after the semiconductor giant announced plans to lay off 1,500 employees. The cuts are expected to hit employees in California and cities around the globe. The cuts are part of the fi

  • [By Timothy Green]

    After trying and failing to acquire mobile-chip giant Qualcomm, Broadcom (NASDAQ:AVGO) has turned its attention to other targets. The company announced on July 11 that it had agreed to pay $18.9 billion in cash for CA Technologies (NASDAQ:CA), a software company that derives about half its revenue and most of its profits from software and solutions for mainframe systems. Broadcom is making a very big bet on big iron.

  • [By Ashraf Eassa]

    Earlier this year, in the midst of the drama surroundingBroadcom’s (NASDAQ:AVGO) attempted takeover of Qualcomm,Jacobs relinquished his role as chairman but stayed on as a director. Then, shortly after rumors began to surface that he was trying to take Qualcomm private, Jacobs was kicked off the board of directors.

  • [By Ashraf Eassa]

    In November 2017, chip giant Broadcom (NASDAQ:AVGO) offered to buy fellow chipmakerQualcomm (NASDAQ:QCOM) for $70 per share, a 28% premium to Qualcomm’s closing price before speculation about the bid leaked. Qualcomm shares had been significantly depressed prior to Broadcom’s offer amid an ugly legal battle with Apple (NASDAQ:AAPL) that threatened to destroy Qualcomm’s wireless technology licensing operation — its biggest profit center.

Best Value Stocks For 2019: Vascular Biogenics Ltd.(VBLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading.
    ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday.
    Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent.
    Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday.
    Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter.
    Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday.
    Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading.
    Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss.
    Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook.
    ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering

  • [By Lisa Levin] Companies Reporting Before The Bell
    Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion.
    J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion.
    Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion.
    The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million.
    Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million.
    Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million.
    KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million.
    Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share.
    Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million.
    Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.

     

Best Value Stocks For 2019: Xinyuan Real Estate Co Ltd(XIN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Mixin (CURRENCY:XIN) traded up 6.2% against the U.S. dollar during the 1-day period ending at 20:00 PM E.T. on July 17th. One Mixin token can currently be purchased for approximately $550.98 or 0.07481400 BTC on popular cryptocurrency exchanges. Mixin has a total market cap of $241.93 million and approximately $90,201.00 worth of Mixin was traded on exchanges in the last day. Over the last week, Mixin has traded up 19.1% against the U.S. dollar.

  • [By Shane Hupp]

    Xinyuan Real Estate Co., Ltd. (NYSE:XIN) declared a quarterly dividend on Wednesday, May 30th, RTT News reports. Stockholders of record on Monday, June 11th will be given a dividend of 0.05 per share by the financial services provider on Friday, June 22nd. This represents a $0.20 annualized dividend and a dividend yield of 3.74%.

  • [By Ethan Ryder]

    Mixin (XIN) is a proof-of-stake (PoS) token that uses the SHA256 hashing algorithm. It launched on October 2nd, 2017. Mixin’s total supply is 1,000,000 tokens and its circulating supply is 438,115 tokens. Mixin’s official message board is mixin.one/logs. Mixin’s official Twitter account is @XIN_Foundation and its Facebook page is accessible here. The official website for Mixin is mixin.one.

Best Value Stocks For 2019: Chatham Lodging Trust (REIT)(CLDT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Chatham Lodging (NYSE:CLDT) announced a monthly dividend on Thursday, May 10th, Zacks reports. Shareholders of record on Thursday, May 31st will be paid a dividend of 0.11 per share by the real estate investment trust on Friday, June 29th. This represents a $1.32 annualized dividend and a yield of 6.38%. The ex-dividend date of this dividend is Wednesday, May 30th.

Chatham Lodging (CLDT) Shares Bought by Teachers Insurance & Annuity Association of America

Teachers Insurance & Annuity Association of America raised its holdings in shares of Chatham Lodging (NYSE:CLDT) by 19.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 59,609 shares of the real estate investment trust’s stock after purchasing an additional 9,743 shares during the quarter. Teachers Insurance & Annuity Association of America owned 0.13% of Chatham Lodging worth $1,142,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in CLDT. Advisor Group Inc. lifted its position in shares of Chatham Lodging by 91.0% during the fourth quarter. Advisor Group Inc. now owns 7,652 shares of the real estate investment trust’s stock worth $174,000 after purchasing an additional 3,645 shares during the last quarter. Aperio Group LLC bought a new stake in shares of Chatham Lodging in the fourth quarter valued at about $223,000. BlueCrest Capital Management Ltd bought a new stake in shares of Chatham Lodging in the fourth quarter valued at about $257,000. AMP Capital Investors Ltd bought a new stake in shares of Chatham Lodging in the fourth quarter valued at about $323,000. Finally, Quadrature Capital Ltd bought a new stake in shares of Chatham Lodging in the fourth quarter valued at about $334,000. Institutional investors and hedge funds own 88.21% of the company’s stock.

Get Chatham Lodging alerts:

In other Chatham Lodging news, Chairman Jeffrey H. Fisher purchased 5,500 shares of the company’s stock in a transaction dated Wednesday, February 28th. The shares were acquired at an average price of $18.48 per share, for a total transaction of $101,640.00. Following the completion of the purchase, the chairman now owns 691,545 shares of the company’s stock, valued at $12,779,751.60. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director C Gerald Goldsmith purchased 5,000 shares of the company’s stock in a transaction dated Monday, March 5th. The shares were acquired at an average price of $18.32 per share, for a total transaction of $91,600.00. Following the purchase, the director now directly owns 26,328 shares of the company’s stock, valued at approximately $482,328.96. The disclosure for this purchase can be found here. Insiders have bought 14,715 shares of company stock worth $270,485 in the last 90 days. Insiders own 3.40% of the company’s stock.

Several analysts recently weighed in on the company. Zacks Investment Research upgraded Chatham Lodging from a “hold” rating to a “buy” rating and set a $22.00 price objective for the company in a report on Wednesday. ValuEngine downgraded shares of Chatham Lodging from a “buy” rating to a “hold” rating in a report on Wednesday, May 2nd. Cantor Fitzgerald set a $20.00 target price on shares of Chatham Lodging and gave the stock a “hold” rating in a report on Thursday, March 1st. Barclays reduced their target price on shares of Chatham Lodging from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday, February 27th. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $20.00 target price on shares of Chatham Lodging in a report on Tuesday, February 27th. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $20.83.

Shares of Chatham Lodging stock opened at $19.61 on Friday. The stock has a market capitalization of $896.78 million, a price-to-earnings ratio of 9.16 and a beta of 1.06. The company has a quick ratio of 1.39, a current ratio of 1.39 and a debt-to-equity ratio of 0.67. Chatham Lodging has a one year low of $19.42 and a one year high of $19.58.

Chatham Lodging (NYSE:CLDT) last announced its earnings results on Tuesday, May 1st. The real estate investment trust reported $0.06 EPS for the quarter, missing the Zacks’ consensus estimate of $0.35 by ($0.29). The firm had revenue of $74.03 million during the quarter, compared to the consensus estimate of $70.78 million. Chatham Lodging had a return on equity of 3.69% and a net margin of 9.12%. sell-side analysts anticipate that Chatham Lodging will post 1.93 EPS for the current year.

The firm also recently declared a monthly dividend, which will be paid on Friday, June 29th. Stockholders of record on Thursday, May 31st will be paid a dividend of $0.11 per share. The ex-dividend date of this dividend is Wednesday, May 30th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 6.73%. Chatham Lodging’s payout ratio is 61.68%.

Chatham Lodging Profile

Chatham Lodging Trust is a self-advised, publicly-traded real estate investment trust focused primarily on investing in upscale, extended-stay hotels and premium-branded, select-service hotels. The company owns interests in 135 hotels totaling 18,516 rooms/suites, comprised of 40 properties it wholly owns with an aggregate of 6,018 rooms/suites in 15 states and the District of Columbia and a minority investment in two joint ventures that own 95 hotels with an aggregate of 12,498 rooms/suites.

Want to see what other hedge funds are holding CLDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chatham Lodging (NYSE:CLDT).

Institutional Ownership by Quarter for Chatham Lodging (NYSE:CLDT)